These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 12431802
21. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism. Borges MH, DiNinno FB, Lengyel AM. Clin Endocrinol (Oxf); 1997 Jun; 46(6):713-8. PubMed ID: 9274702 [Abstract] [Full Text] [Related]
22. Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers. Frieboes RM, Antonijevic IA, Held K, Murck H, Pollmächer T, Uhr M, Steiger A. Psychoneuroendocrinology; 2004 Aug; 29(7):851-60. PubMed ID: 15177700 [Abstract] [Full Text] [Related]
23. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents. Laron Z, Bowers CY, Hirsch D, Almonte AS, Pelz M, Keret R, Gil-Ad I. Acta Endocrinol (Copenh); 1993 Nov; 129(5):424-6. PubMed ID: 8279223 [Abstract] [Full Text] [Related]
26. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO. J Clin Endocrinol Metab; 1990 Apr; 70(4):975-82. PubMed ID: 2108187 [Abstract] [Full Text] [Related]
27. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6). Correa-Silva SR, Nascif SO, Molica P, Sá LB, Vieira JG, Lengyel AM. Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623 [Abstract] [Full Text] [Related]
28. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Thomas GB, Fairhall KM, Robinson IC. Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719 [Abstract] [Full Text] [Related]
29. Oral activity of the growth hormone releasing peptide His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in rats, dogs and monkeys. Walker RF, Codd EE, Barone FC, Nelson AH, Goodwin T, Campbell SA. Life Sci; 1990 Apr; 47(1):29-36. PubMed ID: 2117689 [Abstract] [Full Text] [Related]
30. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion. Muller AF, Janssen JA, Lamberts SW, Bidlingmaier M, Strasburger CJ, Hofland L, van der Lely AJ. Clin Endocrinol (Oxf); 2001 Oct; 55(4):461-7. PubMed ID: 11678828 [Abstract] [Full Text] [Related]
31. Abuse of recombinant human growth hormone: studies in two different dog models. Rigamonti AE, Scanniffio D, Bonomo SM, Cella SG, Sartorio A, Müller EE. Neuroendocrinology; 2004 Oct; 79(5):237-46. PubMed ID: 15218318 [Abstract] [Full Text] [Related]
36. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Leal-Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF. Clin Endocrinol (Oxf); 1994 Nov; 41(5):649-54. PubMed ID: 7828354 [Abstract] [Full Text] [Related]
39. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy. Popovic V, Simic M, Ilic L, Micic D, Damjanovic S, Djurovic M, Obradovic S, Dieguez C, Casanueva F. Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075 [Abstract] [Full Text] [Related]